Tracy Newkirk
Neurology · Greenbrae, CANPI 1477630259
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.0% of the total across 194 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Avanir Pharmaceuticals, Inc. at 45.4% of the total. Reporting peaked in 2020 at $730 and has fallen 91.3% since, to $64 in 2023.
Across 194 payments — averaging $12.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Avanir Pharmaceuticals, Inc.$1K
- AbbVie$745
- Teva Pharmaceuticals USA, Inc.$260
- Amgen$113
- Lilly USA, LLC$82
- Neurelis, Inc.$32
- plus $106 from 5 others
What the payments were for
- Food & beverage$2,32695%
- Education$1235%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Avanir Pharmaceuticals, Inc. | 108 | $1,111 |
| AbbVie(2 entities) | 48 | $745 |
| Teva Pharmaceuticals USA, Inc. | 15 | $260 |
| Amgen | 9 | $113 |
| Lilly USA, LLC | 5 | $82 |
| Neurelis, Inc. | 2 | $32 |
| Novartis | 2 | $31 |
| Biohaven Pharmaceuticals, Inc. | 2 | $31 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $20 |
| Impel Pharmaceuticals Inc. | 1 | $12 |
| Assertio Therapeutics, Inc. | 1 | $12 |
How this compares
$2,449 in reported general payments places this provider in the 60th percentile of 1,996 neurology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 12 | $5,317 |
Paid to pharmacies, not to this prescriber.
Other neurology in Greenbrae
- Andrew BlumenfeldCarlsbad$4.9M
- Khashayar DashtipourLoma Linda$3.3M
- Regina BerkovichWest Hollywood$3M
- Daniel BandariNewport Beach$2.6M
- Perry ShiehLos Angeles$2.4M
- Sandeep ThakkarIrvine$2M
- David LiebeskindLos Angeles$1.9M
- Jack SchimCarlsbad$1.7M
- Parshaw DorrizMission Viejo$1.5M
- Benjamin FrishbergCarlsbad$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.